key: cord-0875268-dqy7z2ar
authors: Weiner, Menachem M.; Reich, David L.
title: Lessons Learned from COVID-19 Resource Management at a New York Hospital
date: 2020-11-12
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2020.11.015
sha: 542481a471bef8654c96537870d49ef5a7407a56
doc_id: 875268
cord_uid: dqy7z2ar

nan

The novel coronavirus disease 2019 (COVID-19) was declared a global pandemic by the World Health Organization in early 2020. The first reported cases in the United States were at the end of January in the west coast states of Washington and California and the first case of COVID-19 was diagnosed in New York City a month later.

However, by mid-April, the rate of infections in New York State had exceeded every other state accounting for more than 30% of all of the US cases. 1 As the epicenter of the virus, the surge of cases stressed and threatened to overwhelm the state's health care systems due to the volume and acuity of COVID-19 patients. 2 The Mount Sinai Hospital is the academic flagship of an eight-hospital health system affiliated with the Icahn School of Medicine at Mount Sinai located in New York. It averages 4.1 million annual patient visits, has 410 ambulatory practices, and has more than 42,000 employees. By early April, the Health System had over 2000 patients hospitalized with laboratory-confirmed COVID-19. This required the rapid diversion of inpatient and ambulatory resources almost exclusively toward inpatient COVID-19 care.

In the setting of potential overwhelming of the healthcare system, this approach was supported by public health authorities. During this initial surge, we encountered several challenges, including the need to safely increase inpatient and critical care capacity, manage an apprehensive workforce in the setting of many unknowns, innovate testing and therapeutics, and to provide parallel care while preparing for post-surge care.

In order to quickly increase capacity, we took a number of important steps. All nonurgent visits as well as elective and urgent surgeries were deferred. Ambulatory practices immediately moved to telemedicine despite previous hesitancy on the part of both clinicians and patients to engage. All but three inpatient adult medical-surgical units were converted to COVID-19 units. We more than doubled our ICU capacity in less than 3 weeks by placing two patients into single occupancy rooms in our 8 native adult ICUs and converting PACUs to non-COVID ICUs-94 licensed beds became 240 ICU beds. We were also able to increase our number of negative -pressure rooms.

Using HEPA filters and replacing room windows with "cutouts" for exhaust, we converted 260 patient rooms to airborne infection isolation rooms. Finally, we incorporated the use of non-traditional patient care spaces, including the rapid construction of patient units in the hospital lobby and the erection of a field hospital in Central Park. In order not to overwhelm the system, the mildly symptomatic and asymptomatic were asked to stay home to preserve resources, including testing capacity and personal protective equipment (PPE), and to decrease exposures. The inability to test for SARS-CoV-2 hampered early containment efforts. In an effort to preserve initial testing capacity, PPE and potential healthcare worker exposures, diagnostic testing was prioritized to hospitalized patients. Once high-throughput testing was available, the need for rapid, sensitive, and higher volumes of testing became more apparent and continues to be a challenge as influenza season approaches.

One of the most daunting challenges was the need to increase ventilator capacity to multiples of normal capacity. We accomplished this by incorporating the use of nontraditional ventilators and through innovation. Non-traditional ventilator used included anesthesia machines and transport ventilators. Additionally, we leveraged our simulation laboratory to facilitate several ventilator innovations, including the development of a split breathing circuit for shared ventilation that utilized threedimensional printed flow control valves to deliver differential ventilation to two patients connected to a single ventilator 4 and the development of a protocol for the use of bilevel positive airway pressure (BiPAP) machines as an invasive bi-level ventilator. 5 The use of split ventilation and adapted BiPAP devices were not employed clinically, as traditional and transport ventilators were in adequate supply at the peak of the April surge. A fleet of anesthesia machines was used for ventilation for a period of approximately two weeks as a proof of concept and to optimize the redeployment of the anesthesia care team into a patient unit that was converted into an "anesthesia" ICU.

The role of ECMO in COVID-19 remains undetermined. 6 At Mount Sinai, we developed ECMO protocols which remain in place. While we prepared for significant need, this did not materialize and ECMO has not measurably improved outcome.

Concurrent with all clinical efforts, a dynamic and flexible research enterprise evaluated the use of antivirals, 7 immunomodulators, 8 convalescent plasma, 9 and anticoagulation. 10 Collaborations with world-renowned virology and immunology medical school laboratories enabled the transition of research assays into the hospital clinical laboratory, including a cytokine panel and quantitative antibody testing.

Non-pharmaceutical interventions (e.g., masking and social distancing) and aggressive regional mitigation efforts allowed New York to flatten the curve and now we are addressing the physical and fiscal consequences of deferred care and the need to provide parallel non-COVID-19 care and while preparing for potential future surges.

Shortly after the onset of the pandemic, the hospital experienced a sharp decline in non-

Services noted an increase in out of hospital cardiac arrests. Evaluation of national syndromic data noted a decrease in emergency room visits by 42% early in the pandemic, including a 23% decrease for acute myocardial infarctions, 20% for strokes, and 10% for hyperglycemic crises compared to the previous 10 weeks. 11 In New York City, there was a significant and precipitous decrease in the monthly surgical case volume of acute type A aortic dissection from 13±5 cases per month in the 26 months before the COVID-19 pandemic to 3 ±1 in the first 2 months of the NYC surge, raising important health concerns about the collateral effects of the pandemic. 12 Even after the surge was over and despite New York continuing to have a low incidence of new cases, patients remain hesitant to utilize in-person healthcare. In the outpatient setting, a profound decrease in preventative care, including vaccinations, has been noted in the setting of deferred care and hesitancy on the part of patients to come back to in person care. Our crisis communications have transitioned from being primarily staff-directed toward engaging the public to that the return to healthcare is vital and safe. External communication from both public health authorities and health care professionals to reinforce the importance of timely care for medical emergencies, vaccinations and preventative care is critical to address deferred care and the stigma surrounding health care institutions. Providers need to actively assure the public that inpatient and ambulatory areas have implemented appropriate infection prevention practices to ensure the safety of both patients and healthcare workers.

Lessons learned from the initial surge are informing our next steps. We know that PPE works when used appropriately and that staff satisfaction and continued reassessment is important so we need continued strategies for staff fatigue and crisis communication.

The increased incidence of hospital-acquired conditions requires reassessment of practices that were aimed to minimize interactions. The prolonged effects of COVID-19 on the health of New Yorkers, whether it be from the disease itself or interrupted medical care, will continue to affect health systems. Parallel and post-surge care requires strong staff engagement and flexible, dynamic, and forward-thinking leadership. Finally, we must remember that everyone is someone's personvisitors are part of the healing process.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Managing COVID-19 from the epicenter: adaptations and suggestions based on experience

Mount Sinai's Center for Stress, Resilience and Personal Growth as a model for responding to the impact of COVID-19 on health care workers

Mount Sinai HELPS Innovate Group. Differential Ventilation Using Flow Control Valves as a Potential Bridge to Full Ventilatory Support during the COVID-19 Crisis

Repurposing bi-level ventilators for use with intubated patients while minimizing risk to health care workers during insufficient supply of conventional ventilation for patients with COVID-19

Extracorporeal Life Support Organization. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials

STOP-COVID Investigators. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions -United States

The COVID-19 Pandemic and Acute Aortic Dissections in New York: A Matter of Public Health